Table 2.

Patient disposition (initial six months)

			Discontinuations
	n	Completed	Adverse event	Death	Lack of efficacy/ disease progression	Other†
ISIS 2302
2 Week	99	59	5	1*	20	14
4 Week	99	58	3	0	32	6
All ISIS 2302	198	117	8	1*	52	20
Placebo	101	53	2	0	35	11

*Myocardial infarction.

†Withdrew consent, non-compliance, no longer eligible, lost to follow up.